Identification of a Metabolic Reprogramming-Associated Risk Model Related to Prognosis, Immune Microenvironment, and Immunotherapy of Stomach Adenocarcinoma

Figure 1

Establishment of MRGS. (a) Volcano plot regarding MRGS that differentially expressed between STAD samples and normal samples. (b) The intersections of the differentially expressed MRGS and the MRGS with prognostic value for STAD. (c) LASSO Cox regression analysis for STAD samples based on the MRGS in the intersections. (d) Coefficient profiles from the LASSO Cox analysis. (e) Correlation network of the nine candidates MRGS.

(a)

(b)

(c)

(d)

(e)